Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. - Wikidata - awgldk - TriplyDB

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

http://www.wikidata.org/entity/Q37054928

about

Mechanisms underlying the anti-aging and anti-tumor effects of lithocholic bile acid Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus 'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.The role of Epac in the heart.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Unbalanced Growth, Senescence and Aging.The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.A molecular dynamics study of adenylyl cyclase: The impact of ATP and G-protein binding.Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.

P2860

Q34358930-D2536F02-706E-4A7F-AD81-121E2A1E266C Q35035194-B5A27108-723B-472B-9386-2E0D399E959B Q35511952-46BD2319-B3AD-4DDB-9EFB-0C5DC6248C2A Q37245273-BBC13A76-6336-4584-9062-C9CB22EEC199 Q37693261-62C2EB65-A609-46D7-8884-B7A78087298B Q38835689-11B398FE-A2C4-439B-908C-DE792CDBB8BB Q38934306-74BDB310-50CA-4855-907C-DA6046BD3AFA Q39158851-BCBC43B6-9104-45DA-8025-2D120A0F084C Q39363654-823517A2-ED96-4AF2-BC1D-7D7C4A9AB5FA Q41611394-77F338AA-9999-4F81-BEAE-64B7402D38E3 Q46034115-B1E79188-4506-417E-A732-423928B5FD85 Q47638249-79E8FAB1-BFBB-4812-9125-0689703D82DF Q51648446-A6ED8282-11B9-40AB-AD32-03635B263959 Q51739948-CB7C67C4-D7CD-4E1A-BF43-E74EBA1715A5 Q52563694-EDEE0D3D-E758-4C98-9009-76DE55276D38 Q54846617-D2E14CE7-C743-4DC7-9CAA-88B971DF6666

P2860

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

http://www.wikidata.org/entity/Q37054928

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@en

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@nl

type

label

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@en

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@nl

prefLabel

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@en

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

@nl

P1433

Q37054928-8B27F711-8A28-4495-B589-927B6DCC2909

P1476

Q37054928-45DDAB16-5F4D-40EB-8432-1D16A5EEB0E4

P2093

Q37054928-17DD7653-EAC4-48E1-93F8-3429E2BFF4F0

Q37054928-273EF879-DF07-4E52-BE00-B3FE26FBF453

Q37054928-318E2A35-F908-4E07-BC56-61C7C7000E2A

Q37054928-466CD73C-9170-4F78-BB99-CCE30D602AB0

Q37054928-53B0BC40-4DEF-4EF6-946E-023A6844908B

Q37054928-5A453F2C-6A81-4CA7-A933-0990854549A9

Q37054928-8431960F-20F4-45AA-80CF-0F4B08213A1F

Q37054928-BA274013-88BD-4F8D-9239-4256823B5915

P2860

Q37054928-03EE8A53-EA5B-4200-A41E-2337FB64451D

Q37054928-0752D5C3-B27E-44AE-9794-A8FF59B09999

Q37054928-08E18BC0-CD4F-4E1B-A3A2-BB4E2F00FA1A

Q37054928-0A9151AC-A3EF-4BA9-81FE-F16FD7D77623

Q37054928-0E236EC8-F0C6-485B-8B88-022B83A4B290

Q37054928-0ECC2FB6-89D6-438A-9CEE-569FB729B600

Q37054928-1FA7A310-F73C-4368-8EAF-41019F759761

Q37054928-20E7FD26-14EC-4172-950E-B77F925C21D2

Q37054928-26990DB0-6B9E-47A5-AFB9-7609AB084F19

Q37054928-29D677BE-3590-47F4-A90B-4D0FE25E3CCD

P304

Q37054928-76A65277-CCC0-4D3C-882E-E7001B4A7FB9

P31

Q37054928-F87FD69A-3C82-440F-B5FB-03FA79E4C1E9

P356

Q37054928-EA667238-BEDF-40A5-8AD1-EAE80A8CD51B

P433

Q37054928-ED619974-7888-4A38-8054-F3F7B70AA69A

P478

Q37054928-23158CC4-276A-4BE7-A02E-1A016CC1BDE4

P50

Q37054928-59AABAFA-6BB1-43A6-9384-202855A3515B

P577

Q37054928-5BB9050F-665F-4D67-9D33-807E012312AC

P5875

Q37054928-6B51295E-62EC-4582-B0DE-22EE482EE257

P698

Q37054928-E534BD5E-3F3A-490E-977C-AA30028D6D42

P932

Q37054928-EB01127E-288B-459E-B497-7BB59E7BFA31

P356

AJPHEART.00080.2013

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging

@en

P2093

Dorothy E Vatner

http://www.w3.org/2001/XMLSchema#string

Grace J Lee

http://www.w3.org/2001/XMLSchema#string

Jeffrey Pessin

http://www.w3.org/2001/XMLSchema#string

Kousaku Iwatsubo

http://www.w3.org/2001/XMLSchema#string

Lin Yan

http://www.w3.org/2001/XMLSchema#string

Misun Park

http://www.w3.org/2001/XMLSchema#string

Stephen F Vatner

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Ishikawa

http://www.w3.org/2001/XMLSchema#string

P2860

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study

Structure of the adenylyl cyclase catalytic core

Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS

Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium channels

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

Chromosomal mapping of human adenylyl cyclase genes type III, type V and type VI

Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes

An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes

Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts

P304

H1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00080.2013

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236459817

http://www.w3.org/2001/XMLSchema#string

P698

23624627

http://www.w3.org/2001/XMLSchema#string

P932

3727099

http://www.w3.org/2001/XMLSchema#string